Skip to content 
GLP-1 Pharmaceutical Litigation
Ozempic Acquisition
One of the most recognizable names in active pharmaceutical litigation.
Why Ozempic Matters Right Now
Ozempic continues to generate major interest among law firms evaluating active pharmaceutical litigation. It remains one of the most recognizable names in the current tort environment, and that recognition helps support stronger consumer response and broader campaign visibility.
For firms that want to build into a mass tort with significant public awareness, Ozempic remains one of the most important categories to watch.
We acquire claimants across the full GLP-1 family – including Wegovy, Mounjaro, and Zepbound – and validate every signed case against current MDL qualification criteria.
What You Get
Full GLP-1 product coverage
Prescription and treatment timeline captured
MDL-specific injury validation
Real-time signed retainer delivery
Why Ozempic Intake Requires More Verification
The GLP-1 litigation landscape has shifted from volume-based intake to medically vetted case acquisition. Better intake now depends on objective medical support, brand verification, stronger claimant screening, and a process that helps reduce time wasted on weak, duplicative, or non-compliant leads.
As evidentiary standards tighten around stomach paralysis and vision-loss claims, law firms need a more selective intake model that helps prioritize viable files instead of adding administrative drag.
Built for High-Value GLP-1 Claims
Medically focused claimant screening
Exclusive signed-retainer delivery rather than raw leads
Better compliance documentation and audit trails
Cleaner docket development for firms scaling GLP-1 inventories
Compliance and Technical Validation
Ozempic acquisition requires stronger documentation and cleaner provenance. Our process is built around compliance-first intake, documented consent, and technical validation measures – reducing fraud and supporting an audit-ready case flow your firm can defend.
Qualification & Screening Criteria
Gastroparesis or stomach paralysis claims with objective medical support
Ileus claims tied to documented injury history
NAION or vision-loss claims tied to semaglutide use
Brand, duration, and treatment-history verification
Intake review designed to filter out bots, fraud, and non-qualifying submissions
What You Receive
Signed retainers - not raw leads
Medically vetted GLP-1 claimants
Audit-ready consent and chain-of-custody
Coverage across Ozempic, Wegovy, Mounjaro, and Zepbound
Other Featured Mass Torts
Explore the rest of our current top mass tort opportunities.
Asbestos Litigation
Mesothelioma
One of the most established mass tort categories, mesothelioma offers strong case value and consistent demand from individuals and families seeking representation.
PHARMACEUTICAL LITIGATION
Depo-Provera
Long-term use and severe injury allegations have made Depo-Provera a major area of interest for firms expanding their tort practice.
PRODUCT LIABILITY
Hair Relaxer
One of the most visible product liability categories, with strong public familiarity and emotional resonance behind the claim story.
Ready to Build Your Ozempic Docket?
We limit participating firms per tort to protect inventory quality. Reach out to discuss campaign structure and acquisition goals.